Immune Modulation of Recombinant OmpA against Brucella abortus 544 Infection in Mice |
Simborio, Hannah Leah Tadeja
(Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Reyes, Alisha Wehdnesday Bernardo (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Hop, Huynh Tan (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Arayan, Lauren Togonon (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Min, Wongi (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Lee, Hu Jang (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Lee, Jin Ju (Animal and Plant Quarantine Agency) Chang, Hong Hee (Institute of Agriculture and Life Science, Gyeongsang National University) Kim, Suk (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) |
1 | Acha PN, Szyfres B. 2003. Brucellosis, pp. 40-67. In: Zoonoses and Communicable Disease Common to Man and Animals. Vol. 1. Bacterioses and Mycoses. Pan American Health Organization, Washington, DC. |
2 | Akova M, Uzun O, Akalin HE, Haryan M, Unal S, Gur D. 1993. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob. Agents Chemother. 37: 1831-1834. DOI |
3 | Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, et al. 2001. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvants. Infect. Immun. 69: 4816-4822. DOI |
4 | Athanassakis I, Iconomidou B. 1996. Cytokine production in the serum and spleen of mice from day 6 to 14 of gestation: cytokines/placenta/spleen/serum. Dev. Immunol. 4: 247-255. DOI |
5 | Aygen B, Doganay M, Sumerkan B, Yildiz O, Kayabas U. 2002. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Méd. Mal. Infect. 32: 485-493. DOI |
6 | Barrionuevo P, Cassataro J, Delpino MV, Zwerdling A, Pasquevich KA, Garcia Samartino C, et al. 2008. Brucella abortus inhibits major histocompatibility complex III expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect. Immun. 76: 250-262. DOI |
7 | Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J. 2007. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine 25: 6721-6729. DOI |
8 | Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, et al. 2005. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide against Brucella melitensis infection. Infect. Immun. 73: 8079-8088. DOI |
9 | Corbel MJ. 1997. Recent advances in brucellosis. J. Med. Microbiol. 46: 101-103. DOI |
10 | Dabo SM, Confer A, Montelongo M, York P, Wyckoff JH. 2008. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice. Vaccine 26: 4345-4351. DOI |
11 | Eskra L, Canavessi A, Carey M, Splitter G. 2001. Brucella abortus genes identified following constitutive growth and macrophage infection. Infect. Immun. 69: 7736-7742. DOI |
12 | Jimenez de Bagues MP, Barberan M, Marin CM, Blasco JM. 1995. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 13: 301-304. DOI |
13 | Ficht TA, McDonagh MMK, Gamboa AMA, Ficht ACR. 2009. Brucellosis: the case for live, attenuated vaccines. Vaccine 27: 40-43. DOI |
14 | Huang LY, Aliberti J, Leifer CA, Segal DM, Sher A, Golenbock DT, Golding B. 2003. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J. Immun. 171: 1441-1446. DOI |
15 | Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry JP, Delneste Y, et al. 2000. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1: 502-509. DOI |
16 | Lim JJ, Kim DH, Lee JJ, Kim DG, Min W, Lee HJ, et al. 2012. Evaluation of recombinant 28 kDa outer membrane protein of Brucella abortus for the clinical diagnosis of bovine brucellosis in Korea. J. Vet. Med. Sci. 74: 687-691. DOI |
17 | Kaushik P, Singh DK, Kumar SV, Tiwari AK, Shukla G, Dayal S, Chaudhuri P. 2010. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides. Vet. Res. Commun. 34: 119-132. DOI |
18 | Leclerq S, Harms JS, Rosinha GMS, Azevedo V, Oliveira SC. 2002. Induction of a Th1-type of immune respose but not protective immunity by intramuscular DNA immunization with Brucella abortus GroEL heat-shock gene. J. Med. Microbiol. 51: 20-26. DOI |
19 | Lee JJ, Lim JJ, Kim DG, Simborio HL, Kim DH, Reyes AWR, et al. 2014. Characterization of culture supernatant proteins from Brucella abortus and its protection effects against murine brucellosis. Comp. Immunol. Microbiol. Infect. Dis. 37: 221-228. DOI |
20 | Lin J, Huang S, Zhang Q. 2002. Outer membrane proteins: key players for bacterial adaptation in host niches. Microbes Infect. 4: 325-331. DOI |
21 | Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, et al. 2013. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 31: 313-318. DOI |
22 | Lindler LE, Hadfield TL, Tall BD, Snelling NJ, Rubin FA, van de Verg LL. 1996. Cloning of Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect. Immun. 64: 2490-2499. |
23 | Lubroth J, Rweyemamu MM, Viljoen G, Diallo A, Dungo B, Amanfu W. 2007. Veterinary vaccine and their use in developing countries. Rev. Sci. Tech. 26: 179-201. DOI |
24 | Nicoletti PL. 2002. A short history of brucellosis. Vet. Microbiol. 90: 5-9. DOI |
25 | Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC. 2008. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J. Immunol. 180: 1080-1087. DOI |
26 | Makidon PE, Knowlton J, Groom JV, Blanco LP, LiPuma JJ, Bielinska AU, Baker JR. 2010. Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med. Microbiol. Immunol. 199: 81-92. DOI |
27 | Moriyón I, Lopez-Goni I. 1998. Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis. Int. Microbiol. 1: 19-26. |
28 | Pasquevich KA, Estein SM, Samartino CG, Zwerdling A, Coria LM, Barrionuevo P, Cassataro J. 2009. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect. Immun. 77: 436-445. DOI |
29 | Oliveira SC, Splitter GA. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14: 959-962. DOI |
30 | Onate AA, Cespedes S, Cabrera A, Rivers R, Gonzalez A, Munoz C, et al. 2003. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 71: 4857-4861. DOI |
31 | Pore D, Mahata N, Pal A, Chakrabarti MK. 2011. Outer membrane protein (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One 6: e22663. DOI |
32 | Ragan VE. 2002. The animal and plant health inspection service (APHIS) brucellosis eradication program in the United States. Vet. Microbiol. 90: 11-18. DOI |
33 | Schurig GG, Sriranganathan D, Corbel MG. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90: 479-496. DOI |
34 | Soulas C, Baussant T, Aubry JP, Delneste Y, Barillat N, Caron G, et al. 2000. Outer membrane protein A (OmpA) binds to and activates human macrophages. J. Immun. 165: 2335-2340. DOI |
35 | Zhan Y, Liu Z, Cheers C. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisims. Infect. Immun. 64: 2782-2786. |